Medicilon biology department has established an antibody drug development platform, and our team members have more than 10 years experience in custom antibody production. Medicilon\'s hybridoma R&D services can provide a variety of immunization methods (proteins, peptides, small molecules, whole cells) to meet with the client\'s needs.
Development Process of Hybridoma Technology Platform
Experimental Timeline- 01Antigen preparation (provided by the customer or Medicilon)
- 02Standard immunization and serum titer testing
6-8 weeks - 03Fusion screening subclones
4-6 weeks - 04Providing antibody sequence
2 weeks
Service Advantage- Advanced animal facilities:AAALAC certification;Multiple Immunization methods: Medicilon offers various antigen immunization schemes such as protein, peptide, VLP, whole cell and DNA for antigen preparation;High-throughput screening: FACS, ELISA workstation, Biacore affinity, etc., with high screening efficiency;Comprehensive functional testing services:The functional verification testing platform provides in-vitro pharmacodynamic testing services such as Affinity Ranking, Affinity Measurement, EC50 and IC50, and Cross-reactivity; etc.
Advanced Equipment
